Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study.
about
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryPrediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Assessing the Influence of Different Comorbidities Indexes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in a Developing Country.The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMulti-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantationA novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.Patient selection for allogeneic hematopoietic cell transplantation (HCT): the evolution of HCT risk assessment.Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation.Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant.Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality.The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation.
P2860
Q28088365-04D57730-BF90-4009-A39D-D953FC119124Q31052875-3A38AA57-B55E-4041-87C8-4260884C3616Q33886907-5C8BF813-DCD1-4E44-8DE8-1D73BA1441EFQ33978945-3153C369-B83B-47F3-8B79-0204B263F5ECQ34260505-3DC9F8FB-7813-44B1-9785-F6CE9C006CB4Q34769213-24FC824A-883B-43FC-95B5-A263A303EC81Q35783636-E82CF79B-9DDB-4068-B206-0F78D3C5A7CDQ35832484-64B671A0-D9B3-4F28-818A-FA60A3522407Q35864056-0B2A0318-5922-4A13-A24D-6AC1ABB9EB2CQ35882830-0DFBF68E-FE10-44EE-9DA4-F76D993B8332Q35920698-5809919B-85CF-4486-BC56-47659694771CQ36905573-D7045F30-1D1D-4B11-9803-16892E61A16EQ38287009-0D819929-A137-450B-845A-1020F62890A2Q38698528-179F6148-66D6-4533-8231-58D6412491DBQ38858092-CD6FD834-8978-4E4A-9D34-393904B82B2EQ38893877-AA2AE295-FEB6-412C-8205-CD2F0C938A80Q38937601-00307857-9001-4F07-B1DE-1102DAED348AQ40343240-21F26377-71D1-4337-8323-7E5FAF2A9254Q41513936-111FE64A-EA86-4802-B570-03F087C131E7Q47648441-9A99FA6B-11E2-4257-9B55-C8749D2AD739Q50863410-7E44D359-9879-46DC-8FBA-E7D0B0CFEC5A
P2860
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@en
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@nl
type
label
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@en
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@nl
prefLabel
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@en
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@nl
P2093
P1433
P1476
Validation of the Hematopoieti ...... tive, multicenter GITMO study.
@en
P2093
Alberto Bosi
Alberto Tosetto
Alessandro Rambaldi
Andrea Bacigalupo
Francesco Rodeghiero
Renato Fanin
Riccardo Cavazzina
Roberto Raimondi
Rosi Oneto
P304
P356
10.1182/BLOOD-2012-03-414573
P407
P577
2012-06-27T00:00:00Z